186 related articles for article (PubMed ID: 2683460)
1. Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis.
Sansonetti PJ; Arondel J
Vaccine; 1989 Oct; 7(5):443-50. PubMed ID: 2683460
[TBL] [Abstract][Full Text] [Related]
2. OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis.
Sansonetti PJ; Arondel J; Fontaine A; d'Hauteville H; Bernardini ML
Vaccine; 1991 Jun; 9(6):416-22. PubMed ID: 1887672
[TBL] [Abstract][Full Text] [Related]
3. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
Yoshikawa M; Sasakawa C; Okada N; Takasaka M; Nakayama M; Yoshikawa Y; Kohno A; Danbara H; Nariuchi H; Shimada H
Vaccine; 1995; 13(15):1436-40. PubMed ID: 8578822
[TBL] [Abstract][Full Text] [Related]
4. Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y.
Ahmed ZU; Sarker MR; Sack DA
Vaccine; 1990 Apr; 8(2):153-8. PubMed ID: 2186582
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.
Coster TS; Hoge CW; VanDeVerg LL; Hartman AB; Oaks EV; Venkatesan MM; Cohen D; Robin G; Fontaine-Thompson A; Sansonetti PJ; Hale TL
Infect Immun; 1999 Jul; 67(7):3437-43. PubMed ID: 10377124
[TBL] [Abstract][Full Text] [Related]
6. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
Kärnell A; Cam PD; Verma N; Lindberg AA
Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
[TBL] [Abstract][Full Text] [Related]
7. Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.
Fontaine A; Arondel J; Sansonetti PJ
Res Microbiol; 1990; 141(7-8):907-12. PubMed ID: 2101481
[TBL] [Abstract][Full Text] [Related]
8. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP; Cam PD; Trach DD; Lindberg AA
Rev Infect Dis; 1991; 13 Suppl 4():S357-61. PubMed ID: 2047663
[TBL] [Abstract][Full Text] [Related]
9. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
10. Development of an auxotrophic oral live Shigella flexneri vaccine.
Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
[TBL] [Abstract][Full Text] [Related]
11. Potentials of Shigella flexneri Y strain TSF21 as a candidate vaccine against shigellosis: safety, immunogenicity and protective efficacy in Bonnet monkeys.
Ashraf MM; Giri DK; Batra HV; Khandekar P; Ahmed ZU; Talwar GP
FEMS Microbiol Immunol; 1991 Jun; 3(3):165-70. PubMed ID: 1878259
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
[TBL] [Abstract][Full Text] [Related]
15. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.
Bernardini ML; Arondel J; Martini I; Aidara A; Sansonetti PJ
Infect Immun; 2001 Feb; 69(2):1072-83. PubMed ID: 11160004
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
Formal SB; Hale TL; Kapfer C; Cogan JP; Snoy PJ; Chung R; Wingfield ME; Elisberg BL; Baron LS
Infect Immun; 1984 Nov; 46(2):465-9. PubMed ID: 6389344
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization against dysentery.
Kétyi I; Rauss K; Vertényi A
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):81-5. PubMed ID: 4613142
[No Abstract] [Full Text] [Related]
18. Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates.
Simon JK; Wahid R; Maciel M; Picking WL; Kotloff KL; Levine MM; Sztein MB
Vaccine; 2009 Jan; 27(4):565-72. PubMed ID: 19022324
[TBL] [Abstract][Full Text] [Related]
19. Oral immunization of monkeys with polyvalent dysentery vaccine.
Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
[TBL] [Abstract][Full Text] [Related]
20. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
Jennison AV; Roberts F; Verma NK
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
